• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用杀伤毒素的新型抑制策略。

A novel inhibitory strategy of using and killer toxins.

作者信息

Zolfaghari Azadeh, Beheshti-Maal Keivan, Ahadi Ali Mohammad, Monajemi Ramesh

机构信息

Department of Microbiology, Faculty of Biological Sciences, Falavarjan Branch, Islamic Azad University, Isfahan, Iran.

Department of Genetics, Faculty of Science, Shahrekord University, Isfahan, Iran.

出版信息

Future Microbiol. 2025 Feb;20(3):189-199. doi: 10.1080/17460913.2024.2443329. Epub 2024 Dec 20.

DOI:10.1080/17460913.2024.2443329
PMID:39704759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11812320/
Abstract

AIM

Leishmaniasis is a globally prevalent parasitic disease that has drawn significant attention. Killer yeasts offer a novel biological control method, presenting a potential alternative for treating leishmaniasis. This study evaluates the antileishmanial activity of and killer toxins against .

MATERIALS & METHODS: Killer yeasts were isolated using the Well method. The genes encoding K2 and K.L killer toxins were identified by PCR, and the toxins were purified via SDS-PAGE. Antileishmanial and cytotoxic effects on promastigotes and amastigotes were evaluated using the MTT assay.

RESULTS

The first killer isolate was identified as ZBAM (GenBank accession: OQ376749.1) and the second as ZBAM (GenBank accession: OQ401036.1). IC50 values of K2 and K.L toxins against promastigotes were significantly lower than Glucantime and Amphotericin B. The EC50 values at 24 hours for Glucantime, K2, and K.L were 11.83 ± 0.02 μg/ml, 2.35 ± 0.01 μg/ml, and 3.23 ± 0.03 μg/ml, respectively. The EC50 values for K2 and K.L against amastigotes were also lower than Glucantime.

CONCLUSION

This is the first report of the antileishmanial effects of K2 and K.L toxins against , suggesting these yeasts as promising candidates for biological leishmaniasis treatment.

摘要

目的

利什曼病是一种全球流行的寄生虫病,已引起广泛关注。杀伤性酵母提供了一种新的生物控制方法,为治疗利什曼病提供了潜在的替代方案。本研究评估了[具体两种杀伤性酵母]及其杀伤毒素对[利什曼原虫种类]的抗利什曼活性。

材料与方法

采用孔板法分离杀伤性酵母。通过聚合酶链反应(PCR)鉴定编码K2和K.L杀伤毒素的基因,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)纯化毒素。使用噻唑蓝(MTT)法评估对[利什曼原虫种类]前鞭毛体和无鞭毛体的抗利什曼和细胞毒性作用。

结果

第一个杀伤性分离株被鉴定为[酵母种类]ZBAM(基因库登录号:OQ376749.1),第二个为[酵母种类]ZBAM(基因库登录号:OQ401036.1)。K2和K.L毒素对[利什曼原虫种类]前鞭毛体的半数抑制浓度(IC50)值显著低于葡糖胺锑钠和两性霉素B。葡糖胺锑钠、K2和K.L在24小时时的半数有效浓度(EC50)值分别为11.83±0.02μg/ml、2.35±0.01μg/ml和3.23±0.03μg/ml。K2和K.L对[利什曼原虫种类]无鞭毛体的EC50值也低于葡糖胺锑钠。

结论

这是关于K2和K.L毒素对[利什曼原虫种类]抗利什曼作用的首次报道,表明这些酵母有望成为治疗利什曼病的生物制剂。

相似文献

1
A novel inhibitory strategy of using and killer toxins.一种使用杀伤毒素的新型抑制策略。
Future Microbiol. 2025 Feb;20(3):189-199. doi: 10.1080/17460913.2024.2443329. Epub 2024 Dec 20.
2
In Vitro Anti-Leishmanial Activity and Molecular Docking of Eugenol as a Potential Agent Against Leishmania Major.丁香酚作为抗硕大利什曼原虫潜在药物的体外抗利什曼原虫活性及分子对接
Acta Parasitol. 2025 Jul 7;70(4):147. doi: 10.1007/s11686-025-01089-w.
3
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.
4
Interventions for Old World cutaneous leishmaniasis.旧世界皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.
5
Evaluation of Beauvericin's activity and mode of action against all life stages of for cutaneous Leishmaniasis therapy.评价白僵菌素对皮肤利什曼病治疗中所有生命阶段的活性及作用方式。
Front Cell Infect Microbiol. 2025 Jun 10;15:1599766. doi: 10.3389/fcimb.2025.1599766. eCollection 2025.
6
A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents.姜黄素及其衍生物作为抗利什曼原虫药物的有价值来源的系统评价。
Acta Parasitol. 2021 Sep;66(3):797-811. doi: 10.1007/s11686-021-00351-1. Epub 2021 Mar 26.
7
Evaluation of the Antileishmanial Activity of Some Benzimidazole Derivatives Using In Vitro and In Silico Techniques.利用体外和计算机模拟技术评估某些苯并咪唑衍生物的抗利什曼原虫活性
Vet Sci. 2025 Jun 5;12(6):550. doi: 10.3390/vetsci12060550.
8
Oregano essential oil induces death in a resistant strain of isolated from a naturally infected dog through increased production of reactive oxygen species, mitochondrial damage and cell metabolic disruption.牛至精油通过增加活性氧的产生、线粒体损伤和细胞代谢紊乱,诱导从一只自然感染的狗身上分离出的耐药菌株死亡。
Front Cell Infect Microbiol. 2025 Jun 18;15:1601429. doi: 10.3389/fcimb.2025.1601429. eCollection 2025.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
PubChem BioAssays 1063: A Poorly Exploited Source of New Antileishmanial Compounds.《公共化学数据库生物测定1063:新型抗利什曼原虫化合物的未充分利用来源》
J Parasitol Res. 2025 Jun 27;2025:6338486. doi: 10.1155/japr/6338486. eCollection 2025.

本文引用的文献

1
Recent Advances in the Yeast Killer Systems Research.酵母杀伤系统研究的最新进展
Microorganisms. 2023 May 1;11(5):1191. doi: 10.3390/microorganisms11051191.
2
The MTT Assay: A Method for Error Minimization and Interpretation in Measuring Cytotoxicity and Estimating Cell Viability.MTT 检测法:一种用于最小化和解释细胞毒性测量和细胞活力估计中的误差的方法。
Methods Mol Biol. 2023;2644:15-33. doi: 10.1007/978-1-0716-3052-5_2.
3
Identification of Leishmania species and frequency distribution of LRV1 and LRV2 viruses on cutaneous leishmaniasis patients in Isfahan Province, Iran.伊朗伊斯法罕省皮肤利什曼病患者中利什曼原虫种类的鉴定以及LRV1和LRV2病毒的频率分布
Indian J Med Microbiol. 2023 Jan-Feb;41:13-18. doi: 10.1016/j.ijmmb.2022.11.008. Epub 2022 Dec 23.
4
Purification and characterization of a Metschnikowia pulcherrima killer toxin with antagonistic activity against pathogenic microorganisms.一株艳丽枝霉杀真菌毒素的分离纯化与性质鉴定及其对病原微生物的拮抗活性
Arch Microbiol. 2022 May 19;204(6):337. doi: 10.1007/s00203-022-02940-8.
5
Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination.葡萄糖酸锑钠治疗皮肤利什曼病失败:对感染控制和疾病消除的挑战。
PLoS One. 2021 Oct 22;16(10):e0259009. doi: 10.1371/journal.pone.0259009. eCollection 2021.
6
Yeast Killer Toxins' Medical Applications.酵母杀伤毒素的医学应用。
Toxins (Basel). 2021 Sep 15;13(9):655. doi: 10.3390/toxins13090655.
7
Synthesis and Biological Evaluation of Tetrahydropyrimidine and Dihydropyridine Derivatives Against Leishmania Major.四氢嘧啶和二氢吡啶衍生物的合成及对抗利什曼原虫的生物评价。
Acta Parasitol. 2022 Mar;67(1):255-266. doi: 10.1007/s11686-021-00457-6. Epub 2021 Jul 19.
8
Treatment Failure in Cutaneous Leishmaniasis Patients Referred to the School of Public Health, Tehran University of Medical Sciences during 2008-2017.2008年至2017年转诊至德黑兰医科大学公共卫生学院的皮肤利什曼病患者的治疗失败情况。
J Arthropod Borne Dis. 2020 Dec 31;14(4):363-375. doi: 10.18502/jad.v14i4.5274. eCollection 2020 Dec.
9
Peptides to Tackle Leishmaniasis: Current Status and Future Directions.用于治疗利什曼病的肽:现状与未来方向
Int J Mol Sci. 2021 Apr 22;22(9):4400. doi: 10.3390/ijms22094400.
10
Frequency Distribution of Cutaneous Leishmaniasis in the Central Region of Iran.伊朗中部地区皮肤利什曼病的分布频率。
Turkiye Parazitol Derg. 2021 Mar 2;45(1):45-48. doi: 10.4274/tpd.galenos.2020.6808.